KPP Advisory Services LLC Boosts Stock Holdings in Inotiv, Inc. (NASDAQ:NOTV)

KPP Advisory Services LLC increased its position in shares of Inotiv, Inc. (NASDAQ:NOTV) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 275,267 shares of the company’s stock after buying an additional 37,549 shares during the period. KPP Advisory Services LLC owned 1.06% of Inotiv worth $1,140,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Renaissance Technologies LLC raised its stake in shares of Inotiv by 29.9% during the 2nd quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after buying an additional 37,800 shares during the period. Geode Capital Management LLC increased its holdings in Inotiv by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after acquiring an additional 18,039 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its position in Inotiv by 612.5% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock worth $527,000 after acquiring an additional 109,397 shares during the period. Institutional investors and hedge funds own 18.17% of the company’s stock.

Insider Buying and Selling

In other news, Director Nigel Brown bought 7,500 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were bought at an average price of $4.26 per share, with a total value of $31,950.00. Following the completion of the transaction, the director now directly owns 65,537 shares in the company, valued at $279,187.62. This trade represents a 12.92 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO John Gregory Beattie purchased 30,000 shares of the stock in a transaction dated Tuesday, December 10th. The shares were purchased at an average price of $4.75 per share, with a total value of $142,500.00. Following the completion of the transaction, the chief operating officer now owns 161,761 shares of the company’s stock, valued at approximately $768,364.75. This trade represents a 22.77 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 71,029 shares of company stock worth $314,248. Company insiders own 7.80% of the company’s stock.

Inotiv Trading Down 4.0 %

Shares of Inotiv stock opened at $4.28 on Monday. Inotiv, Inc. has a twelve month low of $1.23 and a twelve month high of $11.42. The firm’s 50-day moving average price is $4.37 and its 200 day moving average price is $2.75. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 2.29. The firm has a market capitalization of $111.32 million, a PE ratio of -1.02 and a beta of 3.59.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings results on Tuesday, December 3rd. The company reported ($0.16) earnings per share for the quarter. Inotiv had a negative return on equity of 15.86% and a negative net margin of 22.10%. On average, sell-side analysts predict that Inotiv, Inc. will post -0.75 EPS for the current fiscal year.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.